Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Master Patient Index Software Market by Product Type (Software, Services) and by Deployment (Cloud based, On premises): Global Opportunity Analysis and Industry Forecast, 2023-2032

A13430

Pages: NA

Charts: NA

Tables: NA

Master patient index (MPI) is an imperative and critical component of every healthcare or hospital facility center. MPI software is useful to manage a huge database of patients. MPI software is the main specialty build in the electronic health record (HER) to keep a universal identity of patients at the organizational level. MPI assists in connecting patient records from different databases and lessens data duplication of patients. MPI also aids to avoid inaccuracy of data resulting in inappropriate treatments.

Constant developments in the healthcare sector motivate healthcare providers to adopt healthcare IT solutions for securing easy workflow. MPI software allocates a unique identification number to every patient, and this number enables to maintain, accurate and consistent information of every patient, thereby providing automatic management of patients’ data.

COVID-19 Impact analysis

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

The global outbreak of COVID-19 leads to an ongoing downturn of the healthcare market. Apart from communities, COVID-19 was equally disastrous for major world economies, especially the healthcare sector. Prominent stakeholders are continuing to adapt their strategies to the rapidly changing situation. COVID-19 is projected to have significant long-term impacts on the healthcare industry. Countries and major players would have to undertake critical healthcare changes until the crisis takes a back seat.

 Technological progress, cost containment, and increased access are projected to be an integral part of healthcare reforms in the near future. Digital health and telehealth have taken a front seat in the ongoing outbreak. COVID-19 re-emphasized the importance of remote diagnosis, care, and consultation. Over the past few years, regulatory and behavioral barriers have slowed Telehealth growth. However, since many healthcare providers are currently working on video conferencing and telephone calls, the segment is anticipated to experience growth over the next two years. The social distancing measures also mandated online consultation of patients with moderate symptoms. In addition, it greatly reduced the burden on hospitals already swamped by counts of COVID-19 patients. Medical IoT devices that live at home with patients are now being used for optimizing outpatient treatment and minimizing repeat visits, and these devices can be further used in a crisis situation. The pandemic led to severe resource constraints. This is expected to result in the development of competitive pricing and value-based pricing models, which boosts the growth of the master patient index software market.

Top Impacting Factors

  • Support in managing and maintaining financial, demographic, and clinical data of patients is expected to drive the growth of the master patient index software market.
  • In addition, an increase in healthcare expenditure; collaborations & partnerships between key players to facilitate drug development; and technological advancements, are some factors, which boost the market growth for master patient index software.
  • However, high cost of the software hinders the market growth.

Master Patient Index Software Market Trends

New product launches to flourish the market

In June 2020, Life Image and NextGate, declared a strategic collaboration to address the increasing demand for efficient imaging workflow integration.

In August 2020, Sheba Medical Center and Allscripts have developed a collaboration to enhance the pace of artificial intelligence technology and increase patient safety through the hospitals' ARC Innovation Center. ARC, which stands for accelerate, reinvent, and collaborate, is Sheba Medical Center's research arm, to transform healthcare by 2030.

Key Benefits of the Report

  • This study presents the analytical depiction of the master patient index software industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the master patient index software market share.
  • The current market is quantitatively analyzed to highlight the master patient index software market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed master patient index software market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the master patient index software Report

  • Which are the leading players active in the master patient index software market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the master patient index software market?
  • What future projections would help in taking further strategic steps?
  • What is "Master patient index software"?
  • What is "Master patient index software" Market prediction in the future?
  • Who are the leading global players in the "Master patient index software" Market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "Master patient index software" Market report?                                                                                                                                              

Key Market Segments

  • By Product Type
    • Software
    • Services
  • By Deployment
    • Cloud based
    • On premises
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA


Key Market Players

  • Oracle Corporation
  • Just Associates, Inc.
  • QuadraMed Affinity Corporation
  • Allscripts Healthcare, LLC
  • Wipro Limited
  • Intersystems Corporation
  • NextGate
  • McKesson corporation
  • Verato
  • MEDITECH
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: MASTER PATIENT INDEX SOFTWARE MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Software

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Services

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: MASTER PATIENT INDEX SOFTWARE MARKET, BY DEPLOYMENT

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Deployment

    • 5.2. Cloud Based

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. On Premises

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: MASTER PATIENT INDEX SOFTWARE MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product Type

      • 6.2.3. Market Size and Forecast, By Deployment

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Master Patient Index Software Market

        • 6.2.5.1. Market Size and Forecast, By Product Type
        • 6.2.5.2. Market Size and Forecast, By Deployment
      • 6.2.6. Canada Master Patient Index Software Market

        • 6.2.6.1. Market Size and Forecast, By Product Type
        • 6.2.6.2. Market Size and Forecast, By Deployment
      • 6.2.7. Mexico Master Patient Index Software Market

        • 6.2.7.1. Market Size and Forecast, By Product Type
        • 6.2.7.2. Market Size and Forecast, By Deployment
    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product Type

      • 6.3.3. Market Size and Forecast, By Deployment

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Master Patient Index Software Market

        • 6.3.5.1. Market Size and Forecast, By Product Type
        • 6.3.5.2. Market Size and Forecast, By Deployment
      • 6.3.6. Germany Master Patient Index Software Market

        • 6.3.6.1. Market Size and Forecast, By Product Type
        • 6.3.6.2. Market Size and Forecast, By Deployment
      • 6.3.7. Italy Master Patient Index Software Market

        • 6.3.7.1. Market Size and Forecast, By Product Type
        • 6.3.7.2. Market Size and Forecast, By Deployment
      • 6.3.8. Spain Master Patient Index Software Market

        • 6.3.8.1. Market Size and Forecast, By Product Type
        • 6.3.8.2. Market Size and Forecast, By Deployment
      • 6.3.9. UK Master Patient Index Software Market

        • 6.3.9.1. Market Size and Forecast, By Product Type
        • 6.3.9.2. Market Size and Forecast, By Deployment
      • 6.3.10. Russia Master Patient Index Software Market

        • 6.3.10.1. Market Size and Forecast, By Product Type
        • 6.3.10.2. Market Size and Forecast, By Deployment
      • 6.3.11. Rest Of Europe Master Patient Index Software Market

        • 6.3.11.1. Market Size and Forecast, By Product Type
        • 6.3.11.2. Market Size and Forecast, By Deployment
    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product Type

      • 6.4.3. Market Size and Forecast, By Deployment

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Master Patient Index Software Market

        • 6.4.5.1. Market Size and Forecast, By Product Type
        • 6.4.5.2. Market Size and Forecast, By Deployment
      • 6.4.6. Japan Master Patient Index Software Market

        • 6.4.6.1. Market Size and Forecast, By Product Type
        • 6.4.6.2. Market Size and Forecast, By Deployment
      • 6.4.7. India Master Patient Index Software Market

        • 6.4.7.1. Market Size and Forecast, By Product Type
        • 6.4.7.2. Market Size and Forecast, By Deployment
      • 6.4.8. South Korea Master Patient Index Software Market

        • 6.4.8.1. Market Size and Forecast, By Product Type
        • 6.4.8.2. Market Size and Forecast, By Deployment
      • 6.4.9. Australia Master Patient Index Software Market

        • 6.4.9.1. Market Size and Forecast, By Product Type
        • 6.4.9.2. Market Size and Forecast, By Deployment
      • 6.4.10. Thailand Master Patient Index Software Market

        • 6.4.10.1. Market Size and Forecast, By Product Type
        • 6.4.10.2. Market Size and Forecast, By Deployment
      • 6.4.11. Malaysia Master Patient Index Software Market

        • 6.4.11.1. Market Size and Forecast, By Product Type
        • 6.4.11.2. Market Size and Forecast, By Deployment
      • 6.4.12. Indonesia Master Patient Index Software Market

        • 6.4.12.1. Market Size and Forecast, By Product Type
        • 6.4.12.2. Market Size and Forecast, By Deployment
      • 6.4.13. Rest of Asia Pacific Master Patient Index Software Market

        • 6.4.13.1. Market Size and Forecast, By Product Type
        • 6.4.13.2. Market Size and Forecast, By Deployment
    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product Type

      • 6.5.3. Market Size and Forecast, By Deployment

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Master Patient Index Software Market

        • 6.5.5.1. Market Size and Forecast, By Product Type
        • 6.5.5.2. Market Size and Forecast, By Deployment
      • 6.5.6. South Africa Master Patient Index Software Market

        • 6.5.6.1. Market Size and Forecast, By Product Type
        • 6.5.6.2. Market Size and Forecast, By Deployment
      • 6.5.7. Saudi Arabia Master Patient Index Software Market

        • 6.5.7.1. Market Size and Forecast, By Product Type
        • 6.5.7.2. Market Size and Forecast, By Deployment
      • 6.5.8. UAE Master Patient Index Software Market

        • 6.5.8.1. Market Size and Forecast, By Product Type
        • 6.5.8.2. Market Size and Forecast, By Deployment
      • 6.5.9. Argentina Master Patient Index Software Market

        • 6.5.9.1. Market Size and Forecast, By Product Type
        • 6.5.9.2. Market Size and Forecast, By Deployment
      • 6.5.10. Rest of LAMEA Master Patient Index Software Market

        • 6.5.10.1. Market Size and Forecast, By Product Type
        • 6.5.10.2. Market Size and Forecast, By Deployment
  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. McKesson Corporation

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Oracle Corporation

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Wipro Limited

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Allscripts Healthcare, LLC

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. NextGate

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Just Associates, Inc.

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Verato

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. QuadraMed Affinity Corporation

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. MEDITECH

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Intersystems Corporation

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL MASTER PATIENT INDEX SOFTWARE MARKET, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL MASTER PATIENT INDEX SOFTWARE MARKET FOR SOFTWARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL MASTER PATIENT INDEX SOFTWARE MARKET FOR SERVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL MASTER PATIENT INDEX SOFTWARE MARKET, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL MASTER PATIENT INDEX SOFTWARE MARKET FOR CLOUD BASED, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL MASTER PATIENT INDEX SOFTWARE MARKET FOR ON PREMISES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL MASTER PATIENT INDEX SOFTWARE MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. NORTH AMERICA MASTER PATIENT INDEX SOFTWARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. NORTH AMERICA MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 10. NORTH AMERICA MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 11. U.S. MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 12. U.S. MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 13. CANADA MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 14. CANADA MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 15. MEXICO MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 16. MEXICO MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 17. EUROPE MASTER PATIENT INDEX SOFTWARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. EUROPE MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 19. EUROPE MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 20. FRANCE MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 21. FRANCE MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 22. GERMANY MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 23. GERMANY MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 24. ITALY MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 25. ITALY MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 26. SPAIN MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 27. SPAIN MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 28. UK MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 29. UK MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 30. RUSSIA MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 31. RUSSIA MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 32. REST OF EUROPE MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 33. REST OF EUROPE MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 34. ASIA-PACIFIC MASTER PATIENT INDEX SOFTWARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 35. ASIA-PACIFIC MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 36. ASIA-PACIFIC MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 37. CHINA MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 38. CHINA MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 39. JAPAN MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 40. JAPAN MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 41. INDIA MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 42. INDIA MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 43. SOUTH KOREA MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 44. SOUTH KOREA MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 45. AUSTRALIA MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 46. AUSTRALIA MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 47. THAILAND MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 48. THAILAND MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 49. MALAYSIA MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 50. MALAYSIA MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 51. INDONESIA MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 52. INDONESIA MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 53. REST OF ASIA PACIFIC MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 54. REST OF ASIA PACIFIC MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 55. LAMEA MASTER PATIENT INDEX SOFTWARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 56. LAMEA MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 57. LAMEA MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 58. BRAZIL MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 59. BRAZIL MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 60. SOUTH AFRICA MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 61. SOUTH AFRICA MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 62. SAUDI ARABIA MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 63. SAUDI ARABIA MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 64. UAE MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 65. UAE MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 66. ARGENTINA MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 67. ARGENTINA MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 68. REST OF LAMEA MASTER PATIENT INDEX SOFTWARE, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 69. REST OF LAMEA MASTER PATIENT INDEX SOFTWARE, BY DEPLOYMENT, 2025-2033 ($MILLION)
  • TABLE 70. MCKESSON CORPORATION: KEY EXECUTIVES
  • TABLE 71. MCKESSON CORPORATION: COMPANY SNAPSHOT
  • TABLE 72. MCKESSON CORPORATION: OPERATING SEGMENTS
  • TABLE 73. MCKESSON CORPORATION: PRODUCT PORTFOLIO
  • TABLE 74. MCKESSON CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 75. ORACLE CORPORATION: KEY EXECUTIVES
  • TABLE 76. ORACLE CORPORATION: COMPANY SNAPSHOT
  • TABLE 77. ORACLE CORPORATION: OPERATING SEGMENTS
  • TABLE 78. ORACLE CORPORATION: PRODUCT PORTFOLIO
  • TABLE 79. ORACLE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 80. WIPRO LIMITED: KEY EXECUTIVES
  • TABLE 81. WIPRO LIMITED: COMPANY SNAPSHOT
  • TABLE 82. WIPRO LIMITED: OPERATING SEGMENTS
  • TABLE 83. WIPRO LIMITED: PRODUCT PORTFOLIO
  • TABLE 84. WIPRO LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 85. ALLSCRIPTS HEALTHCARE, LLC: KEY EXECUTIVES
  • TABLE 86. ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT
  • TABLE 87. ALLSCRIPTS HEALTHCARE, LLC: OPERATING SEGMENTS
  • TABLE 88. ALLSCRIPTS HEALTHCARE, LLC: PRODUCT PORTFOLIO
  • TABLE 89. ALLSCRIPTS HEALTHCARE, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 90. NEXTGATE: KEY EXECUTIVES
  • TABLE 91. NEXTGATE: COMPANY SNAPSHOT
  • TABLE 92. NEXTGATE: OPERATING SEGMENTS
  • TABLE 93. NEXTGATE: PRODUCT PORTFOLIO
  • TABLE 94. NEXTGATE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 95. JUST ASSOCIATES, INC.: KEY EXECUTIVES
  • TABLE 96. JUST ASSOCIATES, INC.: COMPANY SNAPSHOT
  • TABLE 97. JUST ASSOCIATES, INC.: OPERATING SEGMENTS
  • TABLE 98. JUST ASSOCIATES, INC.: PRODUCT PORTFOLIO
  • TABLE 99. JUST ASSOCIATES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 100. VERATO: KEY EXECUTIVES
  • TABLE 101. VERATO: COMPANY SNAPSHOT
  • TABLE 102. VERATO: OPERATING SEGMENTS
  • TABLE 103. VERATO: PRODUCT PORTFOLIO
  • TABLE 104. VERATO: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 105. QUADRAMED AFFINITY CORPORATION: KEY EXECUTIVES
  • TABLE 106. QUADRAMED AFFINITY CORPORATION: COMPANY SNAPSHOT
  • TABLE 107. QUADRAMED AFFINITY CORPORATION: OPERATING SEGMENTS
  • TABLE 108. QUADRAMED AFFINITY CORPORATION: PRODUCT PORTFOLIO
  • TABLE 109. QUADRAMED AFFINITY CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 110. MEDITECH: KEY EXECUTIVES
  • TABLE 111. MEDITECH: COMPANY SNAPSHOT
  • TABLE 112. MEDITECH: OPERATING SEGMENTS
  • TABLE 113. MEDITECH: PRODUCT PORTFOLIO
  • TABLE 114. MEDITECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 115. INTERSYSTEMS CORPORATION: KEY EXECUTIVES
  • TABLE 116. INTERSYSTEMS CORPORATION: COMPANY SNAPSHOT
  • TABLE 117. INTERSYSTEMS CORPORATION: OPERATING SEGMENTS
  • TABLE 118. INTERSYSTEMS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 119. INTERSYSTEMS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL MASTER PATIENT INDEX SOFTWARE MARKET SEGMENTATION
  • FIGURE 2. GLOBAL MASTER PATIENT INDEX SOFTWARE MARKET
  • FIGURE 3. SEGMENTATION MASTER PATIENT INDEX SOFTWARE MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN MASTER PATIENT INDEX SOFTWARE MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALMASTER PATIENT INDEX SOFTWARE MARKET
  • FIGURE 11. MASTER PATIENT INDEX SOFTWARE MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. MASTER PATIENT INDEX SOFTWARE MARKET FOR SOFTWARE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. MASTER PATIENT INDEX SOFTWARE MARKET FOR SERVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. MASTER PATIENT INDEX SOFTWARE MARKET SEGMENTATION, BY BY DEPLOYMENT
  • FIGURE 15. MASTER PATIENT INDEX SOFTWARE MARKET FOR CLOUD BASED, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. MASTER PATIENT INDEX SOFTWARE MARKET FOR ON PREMISES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 18. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 19. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 20. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 21. COMPETITIVE DASHBOARD
  • FIGURE 22. COMPETITIVE HEATMAP: MASTER PATIENT INDEX SOFTWARE MARKET
  • FIGURE 23. TOP PLAYER POSITIONING, 2024
  • FIGURE 24. MCKESSON CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 25. MCKESSON CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 26. MCKESSON CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 27. ORACLE CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 28. ORACLE CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 29. ORACLE CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 30. WIPRO LIMITED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 31. WIPRO LIMITED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 32. WIPRO LIMITED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 33. ALLSCRIPTS HEALTHCARE, LLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. ALLSCRIPTS HEALTHCARE, LLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. ALLSCRIPTS HEALTHCARE, LLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. NEXTGATE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. NEXTGATE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. NEXTGATE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. JUST ASSOCIATES, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. JUST ASSOCIATES, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. JUST ASSOCIATES, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. VERATO: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. VERATO: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. VERATO: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. QUADRAMED AFFINITY CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. QUADRAMED AFFINITY CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. QUADRAMED AFFINITY CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. MEDITECH: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. MEDITECH: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. MEDITECH: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. INTERSYSTEMS CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. INTERSYSTEMS CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. INTERSYSTEMS CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Master Patient Index Software Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue